An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.
Source summary generated July 17, 2026; this date does not indicate completed review.
Quotes from three independent practitioners, with their sources. Research context only.
What it is and how it works
From the published literature on Noopept; the papers are listed at the end. Research summary, not a recommendation.
What it is
Noopept (chemical name N-phenylacetyl-L-prolylglycine ethyl ester, research code GVS-111, also called omberacetam) is a small synthetic dipeptide, meaning a molecule built from two amino acids (proline and glycine) with chemical groups added. It was designed in the 1990s at the Zakusov Institute of Pharmacology in Moscow as a peptide relative of the older drug piracetam, and it is sold as a medicine in Russia. Almost all of the published research comes from the Russian group that developed it.
How it works
After it is absorbed, Noopept is broken down into cycloprolylglycine, a small ring-shaped peptide that the body also makes naturally and that the developers regard as the main active form. In rat studies it increased the brain's production of NGF and BDNF (nerve growth factor and brain-derived neurotrophic factor, proteins that help nerve cells survive and form connections) in the hippocampus, the brain region central to memory. In cell studies it activated HIF-1 (a switch protein that turns on the cell's low-oxygen survival genes) and, in a cell model of Alzheimer's disease, reduced oxidative damage, programmed cell death and the abnormal tagging of the tau protein. These findings come from animals and cultured cells; how closely they describe effects in people has not been established.
What it has been studied for
Mild cognitive impairment after vascular or traumatic brain disease (one comparative human trial against piracetam)
Memory and learning in animal models (rodent studies)
Nerve-cell protection in an Alzheimer's-type cell model (cell studies)
Growth-factor signalling in the brain (rat studies)
Strength of the evidence
Early human studiesOne comparative clinical study from Russia against piracetam has been published, alongside a larger body of rodent and cell work from the developing group; no large independent placebo-controlled trial exists.
What the literature reports on safety
In the published Russian comparison with piracetam, Noopept was reported to be well tolerated, but the human safety record is small and comes mainly from one research group. Noopept is not approved by the FDA, and a 2021 analysis found it among unapproved drugs being sold inside United States cognitive-enhancement supplements, where label accuracy was poor. It is a registered medicine in Russia.
Review · Gudasheva TA, Ostrovskaya RU, et al. · Current Pharmaceutical Design (2018) · PMID 30295186
The developers reviewed how Noopept and related dipeptide drugs were designed from natural neuropeptides and summarized the animal and clinical work behind them.
Lab (in vitro) · Vakhitova YV, Sadovnikov SV, et al. · Acta Naturae (2016) · PMID 27099787
Profiled gene activity in cells exposed to Noopept and reported increased activity of the HIF-1 low-oxygen survival pathway and related protective genes.
Cohort study · Neznamov GG, Teleshova ES · Neuroscience and Behavioral Physiology (2009) · PMID 19234797
In patients with mild cognitive problems after vascular or traumatic brain disease, Noopept and piracetam both improved cognitive scores, and Noopept was reported to have fewer side effects.
Lab (in vitro) · Ostrovskaya RU, Vakhitova YV, et al. · Journal of Biomedical Science (2014) · PMID 25096780
In nerve-like cells exposed to the Alzheimer's-linked beta-amyloid fragment, Noopept reduced oxidative stress, cell death and abnormal tau phosphorylation.
Lab (in vitro) · Cohen PA, Avula B, et al. · Neurology: Clinical Practice (2021) · PMID 34484905
Laboratory analysis of ten cognitive supplements sold online in the United States found Noopept (listed as omberacetam) and four other unapproved drugs, and most declared quantities on the labels were inaccurate.
Sources checked: PubMed/PMC (E-utilities esummary on every PMID), written 2026-11-06.
Answers are generated from captured sources and may omit context or contain errors. Check the supporting passages.
What have the teachers said about Noopept? Ask what it is, what they say it does, or where they discuss it. Questions about doses or personal use: ask your own clinician.
AI chat. To generate a reply, your question and recent chat history may be processed by Cloudflare Workers AI, Groq, Google Gemini or OpenRouter, depending on availability. Keep personal health details out of the chat and check the cited sources. Research use only; not medical advice.
All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.